Peptide Clinical Trials intermediate
Linaclotide - First-in-Human (NCT00434993)
Comprehensive reference for Linaclotide - First-in-Human (NCT00434993), a peptide compound with applications in research and therapeutics.
By Encyclopeptide Editorial | 1 min read
peptide-clinical-trials peptide oligopeptide
Overview
Linaclotide - First-in-Human (NCT00434993) is a peptide compound with applications in research and therapeutics.
Structure
Linaclotide - First-in-Human (NCT00434993) belongs to the Peptide Clinical Trials class of peptides. Its structure and properties make it suitable for various research and therapeutic applications.
Applications
Linaclotide - First-in-Human (NCT00434993) has been studied for its potential applications in:
- Biomedical research
- Drug discovery
- Diagnostic applications
- Therapeutic development
References
- Source: peptide-clinical-trials.md
- Database: Wikipept Peptide Database
Test Your Knowledge
Reinforce what you learned about Linaclotide - First-in-Human (NCT00434993) with interactive quizzes on Wikipept.
Take a Quiz on Wikipept